Among HPV-negative enriched HNSCC patient cohorts, the reported frequencies of NOTCH1 truncating and missense mutations range from 4% to 10% and from 7% to 48%, respectively. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.